ERBB2 and non-small cell lung carcinoma: In a study of 933 non-squamous NSCLC cases, no patients with MET gene exon 14 skipping mutation had mutations in KRAS, EGFR, and ERBB2, or rearrangements in ALK, ROS1, and RET (87).